TY - JOUR
T1 - Impact of APOE-epsilon 4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults
AU - ten Kate, Mara
AU - Sanz-Arigita, Ernesto J.
AU - Tijms, Betty M.
AU - Wink, Alle Meije
AU - Clerigue, Montserrat
AU - Garcia-Sebastian, Maite
AU - Izagirre, Andrea
AU - Ecay-Torres, Miriam
AU - Estanga, Ainara
AU - Villanua, Jorge
AU - Vrenken, Hugo
AU - Visser, Pieter Jelle
AU - Martinez-Lage, Pablo
AU - Barkhof, Frederik
PY - 2016/2
Y1 - 2016/2
N2 - The apolipoprotein E ε4 allele (APOE4) and family history of dementia (FH) are well-known risk factors for the development of sporadic Alzheimer's disease. We assessed the effects of these risk factors on gray matter (GM) volume in 295 cognitively healthy middle-aged community-dwelling subjects. Voxel-based morphometry was used to study GM volume differences between high- and low-risk subjects, based on APOE4 carriership (n = 74), first-degree FH (n = 228), or both (n = 62). No significant results were found using a corrected p value. Using a more lenient threshold (p < 0.001 and minimum cluster size of 100 voxels), APOE4 carriers had reduced GM in the striatum compared to noncarriers. Subjects with FH had reduced GM in right precuneus compared to subjects without FH. Maternal and paternal FH provided similar atrophy patterns. APOE4 carriers with FH had GM reductions in bilateral insula compared to subjects with neither APOE4 nor FH. We conclude that a family history of dementia and APOE4 carriership are both associated with regional GM decreases in cognitively healthy middle-aged subjects, with differential effects on brain regions typically affected in Alzheimer's disease.
AB - The apolipoprotein E ε4 allele (APOE4) and family history of dementia (FH) are well-known risk factors for the development of sporadic Alzheimer's disease. We assessed the effects of these risk factors on gray matter (GM) volume in 295 cognitively healthy middle-aged community-dwelling subjects. Voxel-based morphometry was used to study GM volume differences between high- and low-risk subjects, based on APOE4 carriership (n = 74), first-degree FH (n = 228), or both (n = 62). No significant results were found using a corrected p value. Using a more lenient threshold (p < 0.001 and minimum cluster size of 100 voxels), APOE4 carriers had reduced GM in the striatum compared to noncarriers. Subjects with FH had reduced GM in right precuneus compared to subjects without FH. Maternal and paternal FH provided similar atrophy patterns. APOE4 carriers with FH had GM reductions in bilateral insula compared to subjects with neither APOE4 nor FH. We conclude that a family history of dementia and APOE4 carriership are both associated with regional GM decreases in cognitively healthy middle-aged subjects, with differential effects on brain regions typically affected in Alzheimer's disease.
KW - Alzheimer's disease
KW - Dementia
KW - Apolipoprotein E
KW - Family history
KW - Voxel-based morphometry
KW - MRI
U2 - 10.1016/j.neurobiolaging.2015.10.018
DO - 10.1016/j.neurobiolaging.2015.10.018
M3 - Article
C2 - 26827639
SN - 0197-4580
VL - 38
SP - 14
EP - 20
JO - Neurobiology of Aging
JF - Neurobiology of Aging
ER -